PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Metsä Board Oyj (METSA.HE)
5.440.14 (-2.51%)
5.44 - 5.64
4.95 - 8.28
2.1K / 2.4K (Avg.)
-272.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-0.40%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-5.00%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-6.02%
Negative EBIT growth while VALMT.HE is at 27.42%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-6.02%
Negative operating income growth while VALMT.HE is at 27.42%. Joel Greenblatt would press for urgent turnaround measures.
-9.09%
Negative net income growth while VALMT.HE stands at 29.55%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-13.33%
Negative EPS growth while VALMT.HE is at 31.03%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-13.33%
Negative diluted EPS growth while VALMT.HE is at 31.03%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
4.90%
Slight or no buybacks while VALMT.HE is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
4.90%
Slight or no buyback while VALMT.HE is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
2.90%
Positive OCF growth while VALMT.HE is negative. John Neff would see this as a clear operational advantage vs. the competitor.
-9.50%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-36.02%
Negative 10Y revenue/share CAGR while VALMT.HE stands at 30.33%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-12.26%
Negative 5Y CAGR while VALMT.HE stands at 7.95%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-2.71%
Negative 3Y CAGR while VALMT.HE stands at 11.23%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
377.72%
10Y OCF/share CAGR under 50% of VALMT.HE's 1140.56%. Michael Burry would worry about a persistent underperformance in cash creation.
-25.47%
Negative 5Y OCF/share CAGR while VALMT.HE is at 459.52%. Joel Greenblatt would question the firm’s operational model or cost structure.
8.92%
3Y OCF/share CAGR under 50% of VALMT.HE's 20.51%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
11.18%
Below 50% of VALMT.HE's 136.62%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
62.50%
Below 50% of VALMT.HE's 158.50%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
18.18%
Below 50% of VALMT.HE's 111.11%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
17.24%
Equity/share CAGR of 17.24% while VALMT.HE is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
19.67%
5Y equity/share CAGR is in line with VALMT.HE's 19.81%. Walter Schloss would see parallel mid-term profitability and retention policies.
16.32%
3Y equity/share CAGR 1.25-1.5x VALMT.HE's 14.24%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-3.00%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-1.37%
Inventory is declining while VALMT.HE stands at 6.04%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
1.47%
Asset growth well under 50% of VALMT.HE's 3.89%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
-1.54%
We have a declining book value while VALMT.HE shows 7.11%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-0.15%
We’re deleveraging while VALMT.HE stands at 43.21%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-7.45%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.